Deciphering the evolutionary ecology of snake venoms and its impact on snakebite therapy in India
Abstract
Venom, being an adaptive trait, has propelled the expansion of snake lineages across diverse
habitats, such as the biogeographically distinct Indian landscapes. Natural selection optimises
the potency, composition and lineage-specificity of the snake venom arsenal for effective prey
capture or predator deterrence. Therefore, venoms of several closely related snake species have
been documented to exhibit tremendous spatial venom variation owing to their distinct
evolutionary ecology. However, research on venoms in India has predominantly focused on
assessing the compositional variation in certain snake species from restricted locales. These
studies have also evaluated the venom variation only from a biochemical perspective without
considering the ecological and evolutionary significance of such compositional differences.
Hence, several questions pertaining to the evolutionary ecology of Indian snake venoms remain
unanswered.
Naja naja and Daboia russelii are two medically important snake species that are widely
distributed across distinct bioclimatic regions of India, including arid deserts, fertile plains,
rainforests and hot-humid coasts. In addition to their clinical relevance in the snakebite
scenario, these two species are fascinating model systems to understand the relationship
between evolutionary ecology and venom variation. This doctoral thesis was designed to
decipher the relationship between various ecological and environmental determinants and the
variability in N. naja and D. russelii venoms. For this, venoms of wild-caught snakes from the
major biogeographic zones across the country were sampled. A multi-faceted approach
involving proteomics, biochemical analysis, pharmacological assessment and toxicity studies
was employed to characterise the extent of variability. These studies revealed remarkable
intraspecific variation across populations of these two species. The venoms varied significantly
in terms of their composition, functional profiles and toxic potencies.
Further, the contribution of various abiotic, biotic and life history factors in dictating this
variation was evaluated. A theoretical prediction model was developed to explain the variation
observed in the enzymatic activities of D. russelii venom due to the combined effect of
bioclimatic variables in a region. The feeding ecology is amongst the major biotic factors that
drive venom evolution. Therefore, the prey-specificity of N. naja and D. russelii venoms was
examined as a proxy to understand the relationship between compositional variation and diet.
The venom specificity was determined through in vitro binding and in vivo lethality
experiments against distinct prey organisms.
In addition to interpopulation variation, venoms were documented to vary between individuals
within the same population. Therefore, the extent of intersexual and ontogenetic venom
variation within a population was characterised by housing multiple clutches of these
venomous snakes under captivity. The differences and similarities in the venom composition,
potency and specificity across sexes and ontogenetic stages of N. naja and D. russelii
individuals were recorded. While intersexual variation was not observed in either of the
species, marked differences were observed between the venoms of young and adult D. russelii
snakes. However, adult and juvenile stages of N. naja were found to produce functionally
similar venoms. These results shed light on the influence of distinct ecologies on temporal
venom variation across the developmental stages of a species.
Finally, the repercussions of venom variation at various levels on snakebite treatment in India
were investigated by performing WHO-recommended preclinical studies. These studies
highlighted the shortcomings of the currently employed conventional antivenom therapy in
mitigating snakebites across the country. Moreover, the findings of this thesis have also
provided valuable insights for developing advanced snakebite therapeutics, including broadly
neutralising monoclonal antibodies against medically important toxins such as three-finger
toxins and snake venom metalloproteases.
In summary, this thesis deciphers the major drivers of venom variation in two of the medically
important Indian snake species by integrating the knowledge of natural history with their
venom biology. Further, the study also facilitated the identification of regions where current-generation
antivenoms are ineffective, thereby highlighting the necessity for developing
region-specific antivenom solutions. Moreover, the study has opened promising avenues for
the discovery and development of universal recombinant antibody-based therapies that will
ensure standardised and effective snakebite treatment across the globe. These advancements in
snakebite therapeutics have the potential to save the lives, limbs, and livelihood of India’s
thousands of annual snakebite victims.